J&J Loses First Trial on Warnings of Levaquin Risk

Johnson & Johnson must pay $1.1 million in punitive damages to an 82-year-old man who claimed it failed to properly warn of the risks of tendon damage linked to its antibiotic Levaquin, a Minnesota jury said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.